Zirus Antivirotics Condensed

Zirus

antivirotics, featured, gene trap, H1N1, macrophage, Pandemic, Swine Flu, viral infection, Zirus, XVIVO

Scientists at Zirus are working on a new technology platform to cure and manage viral infection through the development of new classes of antivirotics. This animation depicts the life cycle of H1N1 influenza-A virus and the methodology Zirus uses to find appropriate targets.

Watch the NPR featured story on Zirus Antivirotics by Robert Krulwich.

“XVIVO’s professional team met the many challenges posed by a pre-launch product and rendered visually compelling, high quality animations.”
Vice President, Management Supervisor, Ogilvy Healthworld Medical Education